Giyani Metals Corp announced that its high-purity manganese oxide has passed interim Phase 2 testing by US battery tech firm C4V, marking progress for its K.Hill manganese project in Botswana. The tests showed strong electrode density, cycling stability, and capacity retention, with Phase 2 expected to complete within 60 days. Following this, Phase 3 multi-layer pouch cell testing will begin, lasting about six months. The company is also developing two battery-grade manganese products and expects to release a feasibility study this quarter, supported by a potential $225 million US financing letter of intent.
The Rosen Law Firm is investigating claims that the Flow Foundation provided misleading business information to FLOW cryptocurrency investors. Investors who bought FLOW on or before December 27, 2025, and held it through December 29, 2025, may be eli...
Over five trading days from August 3 to 7, US spot Bitcoin ETFs attracted $853.5 million in net inflows, with BlackRock's iShares Bitcoin Trust (IBIT) accounting for $693 million, or 81% of the total. This inflow reversed the previous week's $61.5 mi...
The Rosen Law Firm has announced an investigation into potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. This legal action is significant for investors as it may impact the company's governance and sto...
The JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) combines large-cap Nasdaq stocks with a covered-call strategy to provide monthly income and reduce volatility. It offers a high trailing distribution rate of about 10.9%, which increases during mar...
EyePoint Pharmaceuticals is approaching a critical valuation point with upcoming Phase III LUGANO trial results for its DURAVYU treatment targeting wet age-related macular degeneration (AMD), expected by August 2026. The trial focuses on sustained si...
